Evidence map›Paper›PMID 26616030›Full record

ReviewJournal of the American College of Cardiology2016

Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.

Gregg W Stone, Judith S Hochman, David O Williams, William E Boden, T Bruce Ferguson, Robert A Harrington, David J Maron

2 registry-linked trialsOpen access · greenAbstract readComparative StudyReview
In one paragraph

Review in Journal of the American College of Cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01471522 nacompletednot on this map

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)

TypeinterventionalSponsorNYU Langone HealthRan2012 to 2023Enrolled5,179ConditionsCardiovascular Diseases, Coronary Disease, Coronary Artery Disease, Heart DiseasesArmscardiac catheterization, coronary artery bypass graft surgery, percutaneous coronary intervention, Lifestyle, Medication
NCT01985360 phase4completednot on this map

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Chronic Kidney Disease Trial

TypeinterventionalSponsorNYU Langone HealthRan2014 to 2020Enrolled777ConditionsCardiovascular Diseases, Coronary Artery Disease, Heart Diseases, Myocardial IschemiaArmsCardiac Catheterization, Coronary Artery Bypass Graft Surgery, Percutaneous Coronary Intervention, Lifestyle, Medication
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Update of the Brazilian Guideline on Nuclear Cardiology - 2020.Arquivos brasileiros de cardiologia · 2020
    Guideline
  2. TransEndocardial Injection of Autologous Expanded CD34Stem cell reviews and reports · 2026
    Trial
  3. Initial Invasive or Conservative Strategy for Stable Coronary Disease.The New England journal of medicine · 2020 · on this map
    Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. SPECT myocardial perfusion imaging-based ischemia-guided early coronary revascularization improves survival: More fuel to the fire.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. The risk for subsequent coronary interventions in a local Polish population.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2020
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Gregg W StoneDepartment of Medicine, Columbia University Medical Center, New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, New York. Electronic address: gs2184@columbia.edu.
Judith S HochmanDepartment of Medicine, Cardiovascular Clinical Research Center, New York University School of Medicine, New York, New York.
David O WilliamsDepartment of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
William E BodenDepartment of Medicine, Samuel S. Stratton VA Medical Center, Albany Medical Center and Albany Medical College, Albany, New York.
T Bruce FergusonDepartment of Cardiovascular Sciences, East Carolina Heart Institute, East Carolina University, Greenville, North Carolina.
Robert A HarringtonDepartment of Medicine, Stanford University School of Medicine, Stanford, California.
David J MaronDepartment of Medicine, Stanford University School of Medicine, Stanford, California.
Stanford University · USAlbany Stratton VA Medical Center Albany · USBrigham and Women's Hospital · USEast Carolina University · USNewYork–Presbyterian Hospital · USNew York University · US

Funding

Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
The Ischemia Trial - CCCU01HL105907 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HOCHMAN, JUDITH S · 2011 to 2019
$100.1M
NCATS NIH HHS UL1 TR001445NHLBI NIH HHS U01 HL105907NHLBI NIH HHS U01HL105907
6 · The paper itself

Abstract

All patients with stable ischemic heart disease (SIHD) should be managed with guideline-directed medical therapy (GDMT), which reduces progression of atherosclerosis and prevents coronary thrombosis. Revascularization is also indicated in patients with SIHD and progressive or refractory symptoms, despite medical management. Whether a strategy of routine revascularization (with percutaneous coronary intervention or coronary artery bypass graft surgery as appropriate) plus GDMT reduces rates of death or myocardial infarction, or improves quality of life compared to an initial approach of GDMT alone in patients with substantial ischemia is uncertain. Opinions run strongly on both sides, and evidence may be used to support either approach. Careful review of the data demonstrates the limitations of our current knowledge, resulting in a state of community equipoise. The ongoing ISCHEMIA trial (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches) is being performed to determine the optimal approach to managing patients with SIHD, moderate-to-severe ischemia, and symptoms that can be controlled medically. (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches [ISCHEMIA]; NCT01471522).

Indexed as

Myocardial RevascularizationCardiovascular AgentsHumansMyocardial IschemiaPercutaneous Coronary InterventionQuality of LifeStentsCardiovascular Agentsangina pectoriscoronary artery bypasscoronary artery diseaseguideline-directed medical therapypercutaneous coronary intervention

Identifiers

PMID26616030
PMCPMC5545795
OpenAlexW2172454067

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.